1. Home
  2. REXR vs TECH Comparison

REXR vs TECH Comparison

Compare REXR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rexford Industrial Realty Inc.

REXR

Rexford Industrial Realty Inc.

HOLD

Current Price

$34.98

Market Cap

8.4B

Sector

Real Estate

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$54.05

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REXR
TECH
Founded
2013
1976
Country
United States
United States
Employees
256
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.2B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
REXR
TECH
Price
$34.98
$54.05
Analyst Decision
Hold
Strong Buy
Analyst Count
10
11
Target Price
$41.00
$71.82
AVG Volume (30 Days)
1.8M
2.8M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
4.90%
0.62%
EPS Growth
N/A
N/A
EPS
N/A
0.81
Revenue
N/A
$1,219,635,000.00
Revenue This Year
$0.09
$2.49
Revenue Next Year
$2.99
$6.40
P/E Ratio
$43.28
$66.72
Revenue Growth
N/A
5.23
52 Week Low
$32.14
$43.20
52 Week High
$44.38
$72.16

Technical Indicators

Market Signals
Indicator
REXR
TECH
Relative Strength Index (RSI) 49.20 58.37
Support Level $34.75 $49.98
Resistance Level $36.65 $57.86
Average True Range (ATR) 0.66 1.88
MACD -0.01 0.70
Stochastic Oscillator 43.57 86.56

Price Performance

Historical Comparison
REXR
TECH

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: